These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 35834040)
1. Improved delivery of Mcl-1 and survivin siRNA combination in breast cancer cells with additive siRNA complexes. Santadkha T; Skolpap W; K C R; Ansari A; Kucharski C; Atz Dick T; Uludağ H Invest New Drugs; 2022 Oct; 40(5):962-976. PubMed ID: 35834040 [TBL] [Abstract][Full Text] [Related]
2. Polymeric delivery of siRNA for dual silencing of Mcl-1 and P-glycoprotein and apoptosis induction in drug-resistant breast cancer cells. Aliabadi HM; Mahdipoor P; Uludağ H Cancer Gene Ther; 2013 Mar; 20(3):169-77. PubMed ID: 23449477 [TBL] [Abstract][Full Text] [Related]
3. Additive Polyplexes to Undertake siRNA Therapy against CDC20 and Survivin in Breast Cancer Cells. Parmar MB; K C RB; Löbenberg R; Uludağ H Biomacromolecules; 2018 Nov; 19(11):4193-4206. PubMed ID: 30222931 [TBL] [Abstract][Full Text] [Related]
4. Enhancement of chemosensitivity by simultaneously silencing of Mcl-1 and Survivin genes using small interfering RNA in human myelomonocytic leukaemia. Jafarlou M; Shanehbandi D; Dehghan P; Mansoori B; Othman F; Baradaran B Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1792-1798. PubMed ID: 29113504 [TBL] [Abstract][Full Text] [Related]
5. Dual Targeting of Anti-Apoptotic Proteins Enhances Chemosensitivity of the Acute Myeloid Leukemia Cells. Baradaran B; Nazmabadi R; Ariyan Z; Sakhinia E; Karami H Asian Pac J Cancer Prev; 2022 Jul; 23(7):2523-2530. PubMed ID: 35901361 [TBL] [Abstract][Full Text] [Related]
6. Multiple siRNA delivery against cell cycle and anti-apoptosis proteins using lipid-substituted polyethylenimine in triple-negative breast cancer and nonmalignant cells. Parmar MB; Arteaga Ballesteros BE; Fu T; K C RB; Montazeri Aliabadi H; Hugh JC; Löbenberg R; Uludağ H J Biomed Mater Res A; 2016 Dec; 104(12):3031-3044. PubMed ID: 27465922 [TBL] [Abstract][Full Text] [Related]
7. Silencing of survivin gene by small interfering RNAs produces supra-additive growth suppression in combination with 17-allylamino-17-demethoxygeldanamycin in human prostate cancer cells. Paduano F; Villa R; Pennati M; Folini M; Binda M; Daidone MG; Zaffaroni N Mol Cancer Ther; 2006 Jan; 5(1):179-86. PubMed ID: 16432177 [TBL] [Abstract][Full Text] [Related]
8. Induction of apoptosis by survivin silencing through siRNA delivery in a human breast cancer cell line. Montazeri Aliabadi H; Landry B; Mahdipoor P; Uludağ H Mol Pharm; 2011 Oct; 8(5):1821-30. PubMed ID: 21838308 [TBL] [Abstract][Full Text] [Related]
9. Small interfering RNA-mediated suppression of serum response factor, E2-promotor binding factor and survivin in non-small cell lung cancer cell lines by non-viral transfection. Walker T; Nolte A; Steger V; Makowiecki C; Mustafi M; Friedel G; Schlensak C; Wendel HP Eur J Cardiothorac Surg; 2013 Mar; 43(3):628-33; discussion 633-4. PubMed ID: 23152437 [TBL] [Abstract][Full Text] [Related]
10. [Silencing of survivin gene in Jeko-1 cell line with small interfering RNA]. Liang W; Zhang WJ; Gao QM; Lu HN; Huang BB; Xiu B; Liang AB Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Feb; 20(1):88-92. PubMed ID: 22391172 [TBL] [Abstract][Full Text] [Related]
11. Synergistic effects of 7-O-geranylquercetin and siRNAs on the treatment of human breast cancer. Zuo J; Jiang Y; Zhang E; Chen Y; Liang Z; Zhu J; Zhao Y; Xu H; Liu G; Liu J; Wang W; Zhang S; Zhen Y Life Sci; 2019 Jun; 227():145-152. PubMed ID: 31009625 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and Characterization of a New Cationic Lipid: Efficient siRNA Delivery and Anticancer Activity of Survivin-siRNA Lipoplexes for the Treatment of Lung and Breast Cancers. Vaidya S; Mohod A; Eedara AC; Andugulapati SB; Pabbaraja S ChemMedChem; 2023 Aug; 18(16):e202300097. PubMed ID: 37306531 [TBL] [Abstract][Full Text] [Related]
14. Efficacious gene silencing in serum and significant apoptotic activity induction by survivin downregulation mediated by new cationic gemini tocopheryl lipids. Kumar K; Maiti B; Kondaiah P; Bhattacharya S Mol Pharm; 2015 Feb; 12(2):351-61. PubMed ID: 25438085 [TBL] [Abstract][Full Text] [Related]
15. Small interfering RNA survivin and GRIM-19 co-expression salmonella plasmid inhibited the growth of laryngeal cancer cells in vitro and in vivo. Wen LJ; Gao LF; Jin CS; Zhang HJ; Ji K; Yang JP; Zhao XJ; Wen MJ; Guan GF Int J Clin Exp Pathol; 2013; 6(10):2071-81. PubMed ID: 24133585 [TBL] [Abstract][Full Text] [Related]
16. siRNA-mediated silencing of survivin inhibits proliferation and enhances etoposide chemosensitivity in acute myeloid leukemia cells. Karami H; Baradaran B; Esfahani A; Estiar MA; Naghavi-Behzad M; Sakhinia M; Sakhinia E Asian Pac J Cancer Prev; 2013; 14(12):7719-24. PubMed ID: 24460358 [TBL] [Abstract][Full Text] [Related]
17. Combination of survivin siRNA with neoadjuvant chemotherapy enhances apoptosis and reverses drug resistance in breast cancer MCF-7 cells. Dong H; Yao L; Bi W; Wang F; Song W; Lv Y J Cancer Res Ther; 2015; 11(4):717-22. PubMed ID: 26881507 [TBL] [Abstract][Full Text] [Related]
18. Gene-silencing effects of anti-survivin siRNA delivered by RGDV-functionalized nanodiamond carrier in the breast carcinoma cell line MCF-7. Bi Y; Zhang Y; Cui C; Ren L; Jiang X Int J Nanomedicine; 2016; 11():5771-5787. PubMed ID: 27853365 [TBL] [Abstract][Full Text] [Related]
19. [Suppressing the growth of Hep-2 human laryngeal cancer cells by silencing survivin gene in vitro and in vivo]. Wen LJ; Gao LF; Ji K; Zhang HJ; Fu DN; Yang JP; Xu YP; Chen GW; Jin CS; Zhao XJ Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Aug; 45(8):674-9. PubMed ID: 21055246 [TBL] [Abstract][Full Text] [Related]
20. [Survivin gene silencing inhibits the proliferation of human gastric cancer MGC-803 cells and enhances their sensitivity to celecoxib]. Fang L; Wu HB; Chen XG Nan Fang Yi Ke Da Xue Xue Bao; 2011 Nov; 31(11):1944-8. PubMed ID: 22126788 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]